Detalhe da pesquisa
1.
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
Breast Cancer Res Treat
; 176(2): 321-328, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31016641
2.
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Breast Cancer Res Treat
; 171(3): 637-648, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938395
3.
Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419.
Front Oncol
; 12: 818693, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35992833
4.
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer.
J Immunother Cancer
; 10(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121644
5.
Efficacy and pharmacodynamics of niraparib in BRCA-mutant and wild-type intracranial triple-negative breast cancer murine models.
Neurooncol Adv
; 1(1): vdz005, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32642648
6.
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.
Neuro Oncol
; 19(11): 1481-1493, 2017 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28486691
7.
Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer.
Mol Cancer Ther
; 14(4): 920-30, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25824335
8.
Mechanisms of chromosomal instability in melanoma.
Environ Mol Mutagen
; 55(6): 457-71, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24616037
9.
Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma.
Pigment Cell Melanoma Res
; 27(4): 653-63, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24628946
10.
MERTK receptor tyrosine kinase is a therapeutic target in melanoma.
J Clin Invest
; 123(5): 2257-67, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23585477
11.
A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines.
Pigment Cell Melanoma Res
; 25(4): 514-26, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22540896
12.
Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032.
Radiother Oncol
; 98(3): 394-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21295875
13.
Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts.
Int J Radiat Oncol Biol Phys
; 77(2): 575-81, 2010 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20457354
14.
Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK.
Radiother Oncol
; 93(3): 639-44, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19853943